Abstract:Abstract Abstract 4713 Objective DNA vaccination respresents a novel therapeutic strategy for cancer. Researchs have showed DNA vaccines encoding Wilms tumor gene WT1-Derived HLA *0201-restricted epitopes effectively induce epitope-specific human cytotoxic T-lymphocytes (CTLs) and kill human leukemia cells in vitro. Nevertheless, there is still a need to increase the potency of DNA vaccine and span the HLA diversity of a target population. In this study, we designed polytpoe WT1 DNA vaccine encoding multiple CTL and helper T-lymphocyte (HTL) epitopes and containing HSP70407-426 as immunoadjuvants for immunotherapy. Methods On the basis published data, To design a Multi-epitope gene (Multi-WT1) containing three HLA *0201-restricted, one HLA *2402-restricted epitopes, two HTL epitopes and one universal Th Pan- DR epitope (PADRE) sequence. The construct also included IgG K chain leader sequence as signal peptide to facilitate transport into the endoplasmic reticulum and Kozak sequence at the N-terminus to support translation of the gene transcript. DNA-coding sequesces was used computer-based modeling to optimize proteasome mediated epitope processing through the introdcution of amino acid spacer sequences, then cloned into the eukaryotic vector to construct the plasmid PcDNA3.1(+). Mycobacterial HSP70 fragment including stimulatory domain P407-426 as immunotherapy was fused to the C-terminal of Multi-WT1 for enhancing CTL activity and then inserted to PcDNA3.1(+). Transfection HEK-293T cells with the Multi -WT1-HSP70 and identify the expressed product by Western bolt. Results Most of Multi -WT1 epitopes can be cleaved by software Net Chop 3.1 and PAPROC± analysis. Western blot showed correct expression of target gene in HEK293T cells. Conclusion Multi-WT1-mtHSP70 fusion gene eukaryotic expression vector was successfully designed, which prepared the materials for the research of DNA vaccine. Disclosures: No relevant conflicts of interest to declare.

Immunogenicity of a novel vaccine with VLP as vector for Wilm's tumor

Human Specific CTL Responses to DNA Vaccine of WT1y Product

Design and Construction of Multi-Epitope Fusion Gene Vaccine of Wilm Tumor Gene WT1 and Stimulating Epitope of Mycobacterium Tuberculosis Heat Shock Protein 70

The Ectopic Expression of Survivin T34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer

Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.

WT1 targeting multi-epitope vaccine design for glioblastoma multiforme using immuno-informatics approaches

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

Site-Specific Modification of Virus-Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting Immunity

Wilms tumor gent 1 (WT1)-specific adoptive immunotherapy in hematologic diseases

A Promising New Approach of VEGFR2-based DNA Vaccine for Tumor Immunotherapy.

Expression of Genetically Modified Human Papillomavirus Type 58 L1 Gene and Production of Antisera Against Resultant VLP

An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia

A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies

A Novel Vaccine Containing EphA2 Epitope and LIGHT Plasmid Induces Robust Cellular Immunity Against Glioma U251 Cells

Development of A Listeria Monocytogenes-Based Vaccine Against Hepatocellular Carcinoma

Development and Immunological Evaluation of HLA-specific Chronic Myeloid Leukemia Polyepitope Vaccine in Chinese Population

Exploiting Immunostimulatory Mechanisms of Immunogenic Cell Death to Develop Membrane-Encapsulated Nanoparticles As a Potent Tumor Vaccine.

Active Specific Immunotherapy of Mice Bearing Liver Cancer Using Novel Whole Cell Tumor Vaccine

[Construction of Recombinant Adenoviral Vector Containing Gene of EWS-FLI1 and Antitumor Immunity of Its Modified Dentritic Cell in Vitro].

Generation of Αgal-Enhanced Bifunctional Tumor Vaccine

Studies on the Preparation of Polygene Tumor Vaccine for Lymphoma